1. Manjandavida FP, Shields CL. The role of intravitreal chemotherapy for retinoblastoma. Indian J Ophthalmol. 2015;63(2):141-145.
  2. Abramson DH, Ji X, Francis JH, Catalanotti F, Brodie SE, Habib L. Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds. Br J Ophthalmol. 2019;103(4):488-493.
  3. Raval V, Bowen C, Soto H, Singh A. Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy. Asia Pac J Ophthalmol (Phila). 2020 Sept 9. doi: 10.1097/APO.0000000000000322
  4. Rizzuti AE, Dunkel IJ, Abramson DH. The Adverse Events of Chemotherapy for Retinoblastoma. What are They? Do We Know? Arch Ophthalmology. 2008;126(6):862-865.
  5. Francis JH, Levin AM, Zabor EC, Gobin PY, Abramdon DH. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival. PLoS One. 2018;13(5):e0197081